Franklin Resources Inc Viracta Therapeutics, Inc. Transaction History

Franklin Resources Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.32 - $5.69 $1,029 - $1,763	310 Added 1.05%	29,696 $127,000
Q2 2022 Aug 11, 2022	SELL	$1.87 - $5.0 $26,613 - $71,160	-14,232 Reduced 32.63%	29,386 $114,000
Q3 2021 Nov 12, 2021	BUY	$7.84 - $12.53 $341,965 - $546,533	43,618 New	43,618 $350,000

5.63M

Ticker VIRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,558,200
Market Cap $9.39M
Description
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.